What is estrogen

Estrogens are a group of female hormones that are responsible for the development and function of reproductive organs and the formation of secondary sex characteristics in women. Estrogen also has other functions: keeps cholesterol in control, protects bone health for both women and men and affects your brain (including mood), bones, heart, skin, and other tissues.

Estrogen is produced by the ovaries, adrenal glands and the placenta during pregnancy ¹ and to a lesser extent, by peripheral steroidogenic conversion by fat tissue and by the testes in men ². Women have about four times the amount of estrogens compared with men ³. Follicle-stimulating hormone (FSH) stimulates the ovarian production of estrogens by the granulosa cells of the ovarian follicles and corpora lutea. Some estrogens are also produced in smaller amounts by other tissues such as the liver, pancreas, bone, adrenal glands, skin, brain, adipose tissue ⁴ and the breasts ⁵. These secondary sources of estrogens are especially important in postmenopausal women ⁶. The pathway of estrogen biosynthesis in extragonadal tissues is different. These tissues are not able to synthesize C19 steroids, and therefore depend on C19 supplies from other tissues ⁶ and the level of aromatase ⁷.

In females, synthesis of estrogens starts in theca interna cells in the ovary, by the synthesis of androstenedione from cholesterol. Androstenedione is a substance of weak androgenic activity which serves predominantly as a precursor for more potent androgens such as testosterone as well as estrogen. This compound crosses the basal membrane into the surrounding granulosa cells, where it is converted either immediately into estrone, or into testosterone and then estradiol in an additional step (see Figure 2). The conversion of androstenedione to testosterone is catalyzed by 17β-hydroxysteroid dehydrogenase, whereas the conversion of androstenedione and testosterone into estrone and estradiol, respectively is catalyzed by aromatase, enzymes which are both expressed in granulosa cells. In contrast, granulosa cells lack 17α-hydroxylase and 17,20-lyase, whereas theca cells express these enzymes and 17β-hydroxysteroid dehydrogenase but lack aromatase. Hence, both granulosa and theca cells are essential for the production of estrogen in the ovaries.

Estrogen, along with progesterone, they help regulate the menstrual cycle, are involved in the growth of breasts and the uterus, and help maintain a healthy pregnancy. Though estrogen is considered the main sex hormones for women, they are also found in men and play a role in bone metabolism and growth in both sexes. However, the regulation of human male reproduction is more complex and the role of estrogens is less clear compared to women ⁸.

In humans, the three major endogenous estrogens are estrone (E1), estradiol (E2), and estriol (E3) ⁹. Another type of estrogen called estetrol (E4) is produced only during pregnancy. Quantitatively, estrogens circulate at lower levels than androgens in both men and women ¹⁰. While estrogen levels are significantly lower in males compared to females, estrogens nevertheless also have important physiological roles in males ⁸.

Estrone (E1) is the only estrogen your body makes after menopause (when menstrual periods stop). Estrone (E1) is directly converted from androstenedione (from the adrenal gland) or indirectly from other androgens. Estrone (E1) can also be produced by the ovaries and placenta, testicles, and adipose (fat) tissues. Estradiol (E2) and estrone (E1) can be converted into each other as needed. Estrone (E1) is the primary estrogen in men and in post-menopausal women.

Estradiol (E2) is the most common type in women of childbearing age. Estradiol (E2) is primarily produced in the ovaries in pre-menopausal women and in the testicles in men. Estradiol (E2) is converted from estrone (E1) in post-menopausal women. It is the most potent estrogen and the one that is present in the highest concentration in non-pregnant, pre-menopausal women. Estradiol (E2) levels vary depending on a woman’s age and reproductive status. They are a good marker of ovarian function.

Estriol (E3) is produced by the placenta, with concentrations rising throughout a woman’s pregnancy. Increasing levels are an indication of the health of the pregnancy and developing baby. Estriol (E3) is part of the second trimester maternal serum screen, a test performed to evaluate fetal risk due to certain chromosomal abnormalities. Very low levels of estriol (E3) are present in non-pregnant women or men.

Estetrol (E4) is a weak estrogen steroid hormone which is found in detectable levels only during pregnancy ¹¹. Estetrol (E4) is produced exclusively by the fetal liver ¹¹. Estetrol (E4) is closely related to estriol (E3), which is also a weak estrogen that is found in high quantities only during pregnancy Along with estradiol (E2), estrone (E1), and estriol (E3), estetrol (E4) is a major estrogen in the body, although only during pregnancy.

In addition to their role as natural hormones, estrogens are used as medications, for instance in menopausal hormone therapy and hormonal birth control.

Figure 1. Estrogen chemical structures

Estrogen in Girls and Women

The types and amounts of estrogen normally present in a woman’s blood will vary throughout her lifetime. Levels vary during each menstrual cycle, during pregnancy, and on a daily basis.

At Birth

Estradiol (E2) and estrone (E1) are high but fall within a few days. Concentration levels are minimal during early childhood.

At Puberty

Concentrations of estrone (E1) and estradiol (E2) begin to rise as puberty approaches. These estrogens are responsible for the development of breasts, uterine growth, and (with other hormones) the onset and regulation of menstruation. A moderate amount of estrone (E1) is present from puberty to menopause. This concentration will vary during the day but is otherwise relatively stable.

Estrogen helps bring about the physical changes that turn a girl into a woman. This time of life is called puberty. These changes include:

• Growth of the breasts
• Growth of pubic and underarm hair
• Start of menstrual cycles

Estrogen helps control the menstrual cycle and is important for childbearing.

During Menstruation

The menstrual cycle is approximately 28 days long and consists of two phases, follicular phase and luteal phase. During each cycle, estradiol (E2) and several other hormones normally rise and then fall in a specific sequence throughout the month. Your estrogen levels are highest in the middle of your menstrual cycle and lowest during your period.

During Pregnancy

Estriol (E3) is the primary estrogen present during pregnancy. It is produced by the placenta, starts to rise in the eighth week of pregnancy, and continues to rise throughout the pregnancy. A sharp increase of estriol (E3) occurs approximately 4 weeks prior to the onset of labor. Estriol (E3) circulating in maternal blood is quickly cleared out of the body. Each measurement of estriol is a snapshot of what is happening with the placenta and fetus, but there is also natural daily variation in estriol concentrations.

Estrone (E1) also rises during pregnancy, increasing as much as 10 fold between weeks 24 and 41. After delivery, estrone (E1) falls and estriol (E3) again becomes essentially undetectable.

During Menopause

Estrone (E1) is the primary estrogen present during menopause. Estradiol (E2) concentrations significantly decrease as ovarian production wanes and eventually stabilize at a low level.

Estrogen in Boys and Men

The types and amounts of estrogen normally present in a man’s blood change, but they vary much less over time than a woman’s and they are much lower. The concentration of estrogen in peripheral blood was typically very low in males ¹². Sizable quantities of estrogen were also found in testis ¹³ and in semen ¹⁴. In adult testes the consensus estrogen source was Leydig cells, which were thought to be the only testicular cell capable of estrogen synthesis ¹⁵. However, the role of estrogens in the physiology of the male reproductive tract is still not fully understood ¹⁶ and many questions remain unanswered, and future work will likely reveal further unexpected insights into the role that estrogens play in the male ⁸. The presence of estrogens in the male testis is well documented ¹⁷, and there is clear evidence that estrogens exert a wide range of biological effects in men and not only in women ¹⁸.

Figure 2. Estrogen biosynthesis in males (biochemical pathway of testosterone conversion into estrogen)

What does estrogen do?

While estrogens are present in both men and women, they are usually present at significantly higher levels in women of reproductive age. Estrogens promote the development of female genital organs and features, growth of the endometrium, and inhibit the secretion of follicle-stimulating hormone (FSH) by the pituitary  and other aspects of regulating the menstrual cycle ¹⁹. In males, estrogen regulates certain functions of the reproductive system important to the maturation of sperm ²⁰ and may be necessary for a healthy libido ²¹. The important actions of the endogenous estrogens are mediated by estrogen receptors (ERs), a dimeric nuclear protein that binds to DNA and controls gene expression. Estrogen receptors (ERs) are synthesized in many cell types in two protein forms, ERα and ERβ, which function as transcription factors once bound with their ligand. ERα is expressed in several tissues including uterus, prostate (stroma), ovary, testes, bone, breast, white adipose tissue, liver, and muscle, and ERβ is expressed in colon, prostate (epithelium), testes, salivary gland, bone marrow, and vascular endothelium ²².

Estrogens are primarily involved in the development and maintenance of normal sexual and reproductive function in women ²³. Moreover, estrogens have also been shown to exert a wide range of biological effects in many physiological systems in both women and men ²⁴. Estrogens mitigate post-injury disruption and inflammatory responses ²⁵ and may play a protective role against oxidative stress ²⁶ and muscle damage (by its antioxidant and membrane-stabilizing properties), repair, and inflammation ²⁷. Estradiol also affects satellite cell activation and proliferation, thereby enhancing the growth and recovery potential of cells ²⁷. Moreover, myosin function is affected by age and by estradiol in women ²⁸. Estrogens and ERs in the skeletal muscle cells of women ²⁹ regulate carbohydrate and lipid metabolism. These receptors have been hypothesized to play a role on muscle strength ³⁰ through the action by both estrogens and insulin-like growth factor (IGF)-1 ³¹.

Like other steroid hormones, estrogen enters passively into the cell where it binds to and activates the estrogen receptor. The estrogen:ER complex binds to specific DNA sequences called a hormone response element to activate the transcription of target genes (in a study using an estrogen-dependent breast cancer cell line as model, 89 such genes were identified) ³². Since estrogen enters all cells, its actions are dependent on the presence of the estrogen receptor (ER) in the cell. The estrogen receptor (ER) is expressed in specific tissues including the ovary, uterus and breast. The metabolic effects of estrogen in postmenopausal women has been linked to the genetic polymorphism of the estrogen receptor (ER) ³³.

Overview of estrogen actions

• Structural
  • Mediate formation of female secondary sex characteristics
  • Accelerate metabolism
  • Increase fat store
  • Stimulate endometrial growth
  • Increase uterine growth
  • Increase vaginal lubrication
  • Thicken the vaginal wall
  • Maintenance of vessel and skin
  • Reduce bone resorption, increase bone formation
• Protein synthesis
  • Increase hepatic production of binding proteins
• Coagulation
  • Increase circulating level of factors 2, 7, 9, 10, plasminogen
  • Decrease antithrombin III
  • Increase platelet adhesiveness
• Lipid
  • Increase HDL, triglyceride
  • Decrease LDL, fat deposition
• Fluid balance
  • Salt (sodium) and water retention
  • Increase cortisol, sex hormone binding globulin (SHBG)
• Gastrointestinal tract
  • Reduce bowel motility
  • Increase cholesterol in bile
• Melanin
  • Increase pheomelanin, reduce eumelanin
• Cancer
  • Support hormone-sensitive breast cancers (see section below)
• Lung function
  • Promotes lung function by supporting alveoli (in rodents but probably in humans) ³⁴
• Uterus lining
  • Estrogen together with progesterone promotes and maintains the uterus lining in preparation for implantation of fertilized egg and maintenance of uterus function during gestation period, also upregulates oxytocin receptor in myometrium
• Ovulation
  • Surge in estrogen level induces the release of luteinizing hormone, which then triggers ovulation by releasing the egg from the Graafian follicle in the ovary.
• Sexual behavior
  • Promotes sexual receptivity ³⁵ and induces lordosis behavior ³⁶.
  • Regulates the stereotypical sexual receptivity behavior; this lordosis behavior is estrogen-dependent, which is regulated by the ventromedial nucleus of the hypothalamus ³⁷
  • Sex drive is dependent on androgen levels ³⁸ only in the presence of estrogen, but without estrogen, free testosterone level actually decreases sexual desire (instead of increases sex drive), as demonstrated for those women who have hypoactive sexual desire disorder, and the sexual desire in these women can be restored by administration of estrogen (using oral contraceptive) ³⁹. In non-human mammals, mating desire is triggered by estrogen surge in estrus.

Female pubertal development

Estrogens are responsible for the development of female secondary sexual characteristics during puberty, including breast development, widening of the hips, and female fat distribution. Conversely, androgens are responsible for pubic and body hair growth, as well as acne and axillary odor.

Breast development

Estrogen, in conjunction with growth hormone (GH) and its secretory product insulin-like growth factor 1 (IGF-1), is critical in mediating breast development during puberty, as well as breast maturation during pregnancy in preparation of lactation and breastfeeding ⁴⁰. Estrogen is primarily and directly responsible for inducing the ductal component of breast development ⁴¹, as well as for causing fat deposition and connective tissue growth. It is also indirectly involved in the lobuloalveolar component, by increasing progesterone receptor expression in the breasts ⁴² and by inducing the secretion of prolactin ⁴³. Allowed for by estrogen, progesterone and prolactin work together to complete lobuloalveolar development during pregnancy ⁴⁴.

Androgens such as testosterone powerfully oppose estrogen action in the breasts, such as by reducing estrogen receptor expression in them ⁴⁵.

Female reproductive system

Estrogens are responsible for maturation and maintenance of the vagina and uterus, and are also involved in ovarian function, such as maturation of ovarian follicles. In addition, estrogens play an important role in regulation of gonadotropin secretion. For these reasons, estrogens are required for female fertility.

Brain and behavior

Sex drive

Estrogens are involved in libido (sex drive) in both women and men.

Cognition

Verbal memory scores are frequently used as one measure of higher level cognition. These scores vary in direct proportion to estrogen levels throughout the menstrual cycle, pregnancy, and menopause. Furthermore, estrogens when administered shortly after natural or surgical menopause prevents decreases in verbal memory. In contrast, estrogens have little effect on verbal memory if first administered years after menopause ⁴⁶. Estrogens also have positive influences on other measures of cognitive function ⁴⁷. However the effect of estrogens on cognition is not uniformly favorable and is dependent on the timing of the dose and the type of cognitive skill being measured ⁴⁸.

The protective effects of estrogens on cognition may be mediated by estrogens anti-inflammatory effects in the brain ⁴⁹. Studies have also shown that the Met allele gene and level of estrogen mediates the efficiency of prefrontal cortex dependent working memory tasks ⁵⁰.

Mental health

Estrogen is considered to play a significant role in women’s mental health. Sudden estrogen withdrawal, fluctuating estrogen, and periods of sustained low estrogen levels correlate with significant mood lowering. Clinical recovery from postpartum, perimenopause, and postmenopause depression has been shown to be effective after levels of estrogen were stabilized and/or restored ⁵¹.

Compulsions in male lab mice, such as those in obsessive-compulsive disorder (OCD), may be caused by low estrogen levels. When estrogen levels were raised through the increased activity of the enzyme aromatase in male lab mice, OCD rituals were dramatically decreased. Hypothalamic protein levels in the gene COMT are enhanced by increasing estrogen levels which are believed to return mice that displayed OCD rituals to normal activity. Aromatase deficiency is ultimately suspected which is involved in the synthesis of estrogen in humans and has therapeutic implications in humans having obsessive-compulsive disorder ⁵².

Local application of estrogen in the rat hippocampus has been shown to inhibit the re-uptake of serotonin. Contrarily, local application of estrogen has been shown to block the ability of fluvoxamine to slow serotonin clearance, suggesting that the same pathways which are involved in SSRI efficacy may also be affected by components of local estrogen signaling pathways ⁵³.

Parenthood

Studies have also found that fathers had lower levels of cortisol and testosterone but higher levels of estrogen (estradiol) compared to non-fathers ⁵⁴.

Binge eating

Estrogen may play a role in suppressing binge eating. Hormone replacement therapy using estrogen may be a possible treatment for binge eating behaviors in females. Estrogen replacement has been shown to suppress binge eating behaviors in female mice ⁵⁵. The mechanism by which estrogen replacement inhibits binge-like eating involves the replacement of serotonin (5-HT) neurons. Women exhibiting binge eating behaviors are found to have increased brain uptake of neuron 5-HT, and therefore less of the neurotransmitter serotonin in the cerebrospinal fluid ⁵⁶. Estrogen works to activate 5-HT neurons, leading to suppression of binge like eating behaviors ⁵⁵.

It is also suggested that there is an interaction between hormone levels and eating at different points in the female menstrual cycle. Research has predicted increased emotional eating during hormonal flux, which is characterized by high progesterone and estradiol levels that occur during the mid-luteal phase. It is hypothesized that these changes occur due to brain changes across the menstrual cycle that are likely a genomic effect of hormones. These effects produce menstrual cycle changes, which result in hormone release leading to behavioral changes, notably binge and emotional eating. These occur especially prominently among women who are genetically vulnerable to binge eating phenotypes ⁵⁷.

Binge eating is associated with decreased estradiol and increased progesterone ⁵⁸. Klump et al. ⁵⁹ Progesterone may moderate the effects of low estradiol (such as during dysregulated eating behavior), but that this may only be true in women who have had clinically diagnosed binge episodes. Dysregulated eating is more strongly associated with such ovarian hormones in women with binge episodes than in women without binge episodes ⁵⁹.

The implantation of 17β-estradiol pellets in ovariectomized mice significantly reduced binge eating behaviors and injections of GLP-1 in ovariectomized mice decreased binge-eating behaviors ⁵⁵.

The associations between binge eating, menstrual-cycle phase and ovarian hormones correlated ⁵⁹.

Bone/skeletal system

Estrogens are responsible for both the pubertal growth spurt, which causes an acceleration in linear growth, and epiphyseal closure, which limits height and limb length, in both females and males. In addition, estrogens are responsible for bone maturation and maintenance of bone mineral density throughout life. Due to hypoestrogenism, the risk of osteoporosis increases during menopause.

Cardiovascular system

Women suffer less from heart disease due to vasculo-protective action of estrogen which helps in preventing atherosclerosis ⁶⁰. It also helps in maintaining the delicate balance between fighting infections and protecting arteries from damage thus lowering the risk of cardiovascular disease ⁶¹.

Immune system

Estrogen has anti-inflammatory properties and helps in mobilization of polymorphonuclear white blood cells or neutrophils ⁶¹.

Associated conditions

Estrogens are implicated in various estrogen-dependent conditions, such as ER-positive breast cancer, as well as a number of genetic conditions involving estrogen signaling or metabolism, such as estrogen insensitivity syndrome, aromatase deficiency, and aromatase excess syndrome.

Low estrogen

Women

The most common reason for low estrogen in women is menopause or surgical removal of the ovaries. Symptoms of low estrogen include:

• Menstrual periods that are less frequent or that stop
• Hot flashes (suddenly feeling very warm) and/or night sweats
• Trouble sleeping
• Dryness and thinning of the vagina
• Low sexual desire
• Mood swings
• Dry skin

Some women get menstrual migraine, a bad headache right before their menstrual period, because of the drop in estrogen.

Men

• Low estrogen in men can cause excess belly fat and low sexual desire.

How to increase estrogen

Estrogen foods

Table 1. Foods high in phytoestrogens

[Sources ⁶², ⁶³, ⁶⁴]

Table 2. Isoflavone content of a representative sample of food products including soy based products

[Source ⁶⁵]

Estrogen pills

Estrogen is used in some medicines, including some contraceptives and menopause medications.

In the US, the combined oral contraceptive pill (‘birth control pill’) contains a synthetic version of estrogen. Another type of contraception, the vaginal ring, also contains estrogen. These contraceptives work mainly by preventing the release of eggs from the ovaries.

If you are having problems with menopause symptoms, such as hot flushes and mood swings, you may choose to go on hormone replacement therapy (HRT). HRT includes estrogen taken in the form of a tablet, gel or skin patch, and can be very effective in easing menopausal symptoms.

Estrogen side effects

Side effects of estrogens include breast tenderness, breast enlargement, headache, nausea, fluid retention, and edema among others ⁶⁶. Other side effects of estrogens include an increased risk of blood clots, cardiovascular disease, and, when combined with most progestogens, breast cancer ⁶⁶. In men, estrogens can cause breast development, feminization, infertility, low testosterone levels, and sexual dysfunction among others.

High estrogen

Women

High estrogen symptoms:

• Weight gain, mainly in your waist, hips, and thighs
• Menstrual problems, such as light or heavy bleeding
• Worsening of premenstrual syndrome
• Fibrocystic breasts (non-cancerous breast lumps)
• Fibroids (noncancerous tumors) in the uterus
• Fatigue
• Loss of sex drive
• Feeling depressed or anxious

Men

High estrogen in men can cause:

• Enlarged breasts (gynecomastia)
• Poor erections
• Infertility

Estrogen blocker

Antiestrogen or estrogen receptor blocker (e.g. Tamoxifen) binds to estrogen receptors and inhibit the action of estrogen. Estrogen controls the growth of certain types of breast cancers called estrogen receptor positive cancers. So estrogen blockers (estrogen receptor antagonists) are useful in treating patients with estrogen sensitive breast cancers. Tamoxifen blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. However, the exact way that tamoxifen works against breast cancer is not known, but it may be related to the way it blocks the effects of estrogen on the body.

Tamoxifen is used to treat breast cancer that has spread to other parts of the body in men and women. It may also be used to treat other kinds of cancer, as determined by your doctor. Tamoxifen is used to treat early breast cancer in women who have already been treated with surgery, radiation, and/or chemotherapy. Tamoxifen is used to reduce the risk of developing a more serious type of breast cancer in women who have had ductal carcinoma in situ (DCIS; a type of breast cancer that does not spread outside of the milk duct where it forms) and who have been treated with surgery and radiation.

Tamoxifen may also be used to reduce the risk of developing breast cancer in women who have a high risk of developing breast cancer due to their age, personal medical history, and family medical history. Women at high risk for developing breast cancer are at least 35 years of age and have a combination of risk factors that make their chance of developing breast cancer 1.67% or more over the next 5 years. Your doctor will help to determine your risk of developing breast cancer.

The following are risk factors that may increase your chance of developing breast cancer:

• If you have close family members (mother, sister, or daughter) with breast cancer.
• If you have ever had a breast biopsy or if high-risk changes in your breast(s) have been found from a breast biopsy.
• If you have never been pregnant or if your first pregnancy occurred at a late age.
• If your first menstrual period occurred at an early age.

Before you begin treatment with tamoxifen, you and your doctor should talk about the good this medicine will do as well as the risks of using it.

Tamoxifen is available only with your doctor’s prescription.

This product is available in the following dosage forms:

• Solution
• Tablet

Tamoxifen comes as a tablet to take by mouth. Tamoxifen is usually taken once or twice a day with or without food. Take tamoxifen at around the same time(s) every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain anything you do not understand. Take tamoxifen exactly as directed. Do not take more or less of it or take it more often than prescribed by your doctor.

Swallow tamoxifen tablets whole; do not split, chew, or crush them. Swallow the tablets with water or any other nonalcoholic drink.

If you are taking tamoxifen to prevent breast cancer, you will probably take it for five years. If you are taking tamoxifen to treat breast cancer, your doctor will decide how long your treatment will last. Do not stop taking tamoxifen without talking to your doctor.

If you forget to take a dose of tamoxifen, take the missed dose as soon as you remember it, and take your next dose as usual. However, if it is almost time for your next dose, skip the missed dose and continue your regular dosing schedule. Do not take a double dose to make up for a missed one.

Other uses of antiestrogen

Tamoxifen is also used sometimes to induce ovulation (egg production) in women who do not produce eggs but wish to become pregnant. Tamoxifen is also sometimes used to treat McCune-Albright syndrome (a condition that may cause bone disease, early sexual development, and dark colored spots on the skin in children). Talk to your doctor about the possible risks of using this drug for your condition.

Tamoxifen may be prescribed for other uses; ask your doctor or pharmacist for more information.

What special precautions should I follow?

Before taking tamoxifen:

• tell your doctor and pharmacist if you are allergic to tamoxifen or any other medications.
• tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: aminoglutethimide (Cytadren); anastrazole (Arimidex), bromocriptine (Parlodel); cancer chemotherapy medication such as cyclophosphamide (Cytoxan, Neosar) letrozole (Femara); medroxyprogesterone (Depo-Provera, Provera, in Prempro); phenobarbital; and rifampin (Rifadin, Rimactane). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.
• in addition to the conditions listed in the IMPORTANT WARNING section, tell your doctor if you have or have ever had high blood levels of cholesterol.
• tell your doctor if you are pregnant or plan to become pregnant. You should not plan to become pregnant while taking tamoxifen or for 2 months after your treatment. Your doctor may perform a pregnancy test or tell you to begin your treatment during your menstrual period to be sure that you are not pregnant when you begin taking tamoxifen. You will need to use a reliable nonhormonal method of birth control to prevent pregnancy while you are taking tamoxifen and for 2 months after your treatment. Talk to your doctor about the types of birth control that are right for you, and continue to use birth control even if you do not have regular menstrual periods during your treatment. Stop taking tamoxifen and call your doctor right away if you think you have become pregnant during your treatment. Tamoxifen may harm the fetus.
• tell your doctor if you are breast-feeding. You should not breastfeed during your treatment with tamoxifen.
• tell all of your doctors and other health care providers that you are taking tamoxifen.
• you will still need to look for early signs of breast cancer since it is possible to develop breast cancer even during treatment with tamoxifen. Talk to your doctor about how often you should examine your breasts yourself, have a doctor examine your breasts, and have mammograms (x-ray examinations of the breasts). Call your doctor right away if you find a new lump in your breast.

Antiestrogen side effects

Tamoxifen may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

• increased bone or tumor pain
• pain or reddening around the tumor site
• hot flashes
• nausea
• excessive tiredness
• dizziness
• depression
• headache
• thinning of hair
• weight loss
• stomach cramps
• constipation
• loss of sexual desire or ability (in men)

Some side effects can be serious. If you experience any of the following symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately:

• vision problems
• loss of appetite
• yellowing of the skin or eyes
• unusual bruising or bleeding
• fever
• blisters
• rash
• swelling of the eyes, face, lips, tongue, throat, hands, arms, feet, ankles, or lower legs
• thirst
• muscle weakness
• restlessness

Tamoxifen may increase the risk that you will develop other cancers, including liver cancer. Talk to your doctor about this risk.

Tamoxifen may increase the risk that you will develop cataracts (clouding of the lens in the eye) that may need to be treated with surgery. Talk to your doctor about this risk.

Tamoxifen may cause other side effects. Call your doctor if you have any unusual problems while taking this medication.

Symptoms of overdose may include:

• uncontrollable shaking of a part of the body
• unsteadiness
• dizziness

1. Marieb E (2013). Anatomy & physiology. Benjamin-Cummings. p. 903. ISBN 978-0-321-88760-3.[↩]
2. Exercise-induced muscle damage and the potential protective role of estrogen. Kendall B, Eston R. Sports Med. 2002; 32(2):103-23.[↩]
3. Sex differences in the association of endogenous sex hormone levels and glucose tolerance status in older men and women. Goodman-Gruen D, Barrett-Connor E. Diabetes Care. 2000 Jul; 23(7):912-8.[↩]
4. Plasma precursors of estrogen. II. Correlation of the extent of conversion of plasma androstenedione to estrone with age. J Clin Endocrinol Metab. 1974 Mar;38(3):476-9. https://doi.org/10.1210/jcem-38-3-476[↩]
5. Barakat R, Oakley O, Kim H, Jin J, Ko CJ. Extra-gonadal sites of estrogen biosynthesis and function. BMB Rep. 2016;49(9):488-96. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5227141/[↩]
6. Estrogen production and action. J Am Acad Dermatol. 2001 Sep;45(3 Suppl):S116-24. https://www.ncbi.nlm.nih.gov/pubmed/11511861[↩][↩]
7. DHEA and the intracrine formation of androgens and estrogens in peripheral target tissues: its role during aging. Steroids. 1998 May-Jun;63(5-6):322-8. https://www.ncbi.nlm.nih.gov/pubmed/9618795[↩]
8. Hess RA, Cooke PS. Estrogen in the male: a historical perspective. Biol Reprod. 2018;99(1):27-44. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6044326/[↩][↩][↩]
9. Baker ME. What are the physiological estrogens? Steroids 2013; 78:337-340[↩]
10. Androgen production in women. Fertil Steril. 2002 Apr;77 Suppl 4:S3-5. https://www.ncbi.nlm.nih.gov/pubmed/12007895[↩]
11. Estetrol: a unique steroid in human pregnancy. J Steroid Biochem Mol Biol. 2008 May;110(1-2):138-43. doi: 10.1016/j.jsbmb.2008.03.027. Epub 2008 Mar 29. https://www.ncbi.nlm.nih.gov/pubmed/18462934[↩][↩]
12. Overpeck JG, Colson SH, Hohmann JR, Applestine MS, Reilly JF. Concentrations of circulating steroids in normal prepubertal and adult male and female humans, chimpanzees, rhesus monkeys, rats, mice, and hamsters: a literature survey. J Toxicol Environ Health 1978; 4(5-6):785–803.[↩]
13. Setchell BP, Cox JE. Secretion of free and conjugated steroids by the horse testis into lymph and venous blood. J Reprod Fertil Suppl 1982; 32:123–127[↩]
14. Bujan L, Mieusset R, Audran F, Lumbroso S, Sultan C. Increased oestradiol level in seminal plasma in infertile men. Hum Reprod 1993; 8(1):74–77[↩]
15. van der Molen HJ, Brinkmann AO, de Jong FH, Rommerts FF. Testicular oestrogens. J Endocrinol 1981; 89:33P–46P[↩]
16. Rochira V, Madeo B, Diazzi C, et al. Estrogens and male reproduction. [Updated 2016 Nov 24]. In: De Groot LJ, Chrousos G, Dungan K, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK278933[↩]
17. Schulster M, Bernie AM, Ramasamy R. The role of estradiol in male reproductive function. Asian journal of andrology 2016; 18:435-440[↩]
18. Blakemore J, Naftolin F. Aromatase: Contributions to Physiology and Disease in Women and Men. Physiology (Bethesda, Md) 2016; 31:258-269[↩]
19. Horstman AM, Dillon EL, Urban RJ, Sheffield-Moore M. The role of androgens and estrogens on healthy aging and longevity. J Gerontol A Biol Sci Med Sci. 2012;67(11):1140-52. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636678/[↩]
20. Hess RA, Bunick D, Lee KH, et al. A role for oestrogens in the male reproductive system. Nature. 1997;390(6659):509-12. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5719867/[↩]
21. Estrogen deficiency leads to apoptosis in dopaminergic neurons in the medial preoptic area and arcuate nucleus of male mice. Mol Cell Neurosci. 2004 Dec;27(4):466-76. https://www.ncbi.nlm.nih.gov/pubmed/15555924[↩]
22. Dahlman-Wright K, Cavailles V, Fuqua SA, et al. International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev. 2006;58(4):773–781.[↩]
23. Heldring N, Pike A, Andersson S, et al. Estrogen receptors: how do they signal and what are their targets. Physiol Rev. 2007;87(3):905–931.[↩]
24. Katzenellenbogen BS, Montano MM, Le Goff P, et al. Antiestrogens: mechanisms and actions in target cells. J Steroid Biochem Mol Biol. 1995;53(1–6):387–393[↩]
25. Kendall B, Eston R. Exercise-induced muscle damage and the potential protective role of estrogen. Sports Med. 2002;32(2):103–123.[↩]
26. Vina J, Sastre J, Pallardo FV, Gambini J, Borras C. Role of mitochondrial oxidative stress to explain the different longevity between genders: protective effect of estrogens. Free Radic Res. 2006;40(12):1359–1365.[↩]
27. MacNeil LG, Baker SK, Stevic I, Tarnopolsky MA. 17beta-estradiol attenuates exercise-induced neutrophil infiltration in men. Am J Physiol Regul Integr Comp Physiol. 2011;300(6):R1443–R1451.[↩][↩]
28. Enns DL, Tiidus PM. The influence of estrogen on skeletal muscle: sex matters. Sports Med. 2010;40(1):41–58.[↩]
29. Lemoine S, Granier P, Tiffoche C, Rannou-Bekono F, Thieulant ML, Delamarche P. Estrogen receptor alpha mRNA in human skeletal muscles. Med Sci Sports Exerc. 2003;35(3):439–443.[↩]
30. Longcope C. Androgen metabolism and the menopause. Semin Reprod Endocrinol. 1998;16(2):111–115.[↩]
31. Wiik A, Ekman M, Johansson O, Jansson E, Esbjornsson M. Expression of both oestrogen receptor alpha and beta in human skeletal muscle tissue. Histochem Cell Biol. 2009;131(2):181–189.[↩]
32. Lin CY, Ström A, Vega VB, et al. Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells. Genome Biol. 2004;5(9):R66. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC522873/[↩]
33. Effect of estrogen receptor β A1730G polymorphism on ABCA1 gene expression response to postmenopausal hormone replacement therapy. Genet Test Mol Biomarkers. 2011 Jan-Feb;15(1-2):11-5. doi: 10.1089/gtmb.2010.0106. Epub 2010 Nov 30. https://www.ncbi.nlm.nih.gov/pubmed/21117950[↩]
34. Estrogen regulates pulmonary alveolar formation, loss, and regeneration in mice. Am J Physiol Lung Cell Mol Physiol. 2004 Dec;287(6):L1154-9. Epub 2004 Aug 6. https://www.ncbi.nlm.nih.gov/pubmed/15298854[↩]
35. Christensen A, Dewing P, Micevych P. Membrane-initiated estradiol signaling induces spinogenesis required for female sexual receptivity. J Neurosci. 2011;31(48):17583-9. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4709636/[↩]
36. Handa RJ, Ogawa S, Wang JM, Herbison AE. Roles for oestrogen receptor β in adult brain function. J Neuroendocrinol. 2012;24(1):160-73. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3348521/[↩]
37. Mapping of neural and signal transduction pathways for lordosis in the search for estrogen actions on the central nervous system. Behav Brain Res. 1998 May;92(2):169-80. https://www.ncbi.nlm.nih.gov/pubmed/9638959[↩]
38. Combined esterified estrogens and methyltestosterone versus esterified estrogens alone in the treatment of loss of sexual interest in surgically menopausal women. Menopause. 2005 Jul-Aug;12(4):374-84. Epub 2005 Jul 21. https://www.ncbi.nlm.nih.gov/pubmed/16037752[↩]
39. Sexual desire, sexual arousal and hormonal differences in premenopausal US and Dutch women with and without low sexual desire. Horm Behav. 2011 May;59(5):772-9. doi: 10.1016/j.yhbeh.2011.03.013. Epub 2011 Apr 14. https://www.ncbi.nlm.nih.gov/pubmed/21514299[↩]
40. Brisken C, O’Malley B. Hormone action in the mammary gland. Cold Spring Harb Perspect Biol. 2010;2(12):a003178. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2982168/[↩]
41. Norman AW, Henry HL (30 July 2014). Hormones. Academic Press. p. 311. ISBN 978-0-08-091906-5.[↩]
42. Coad J, Dunstall M (2011). Anatomy and Physiology for Midwives, with Pageburst online access,3: Anatomy and Physiology for Midwives. Elsevier Health Sciences. p. 413. ISBN 978-0-7020-3489-3.[↩]
43. Silbernagl S, Despopoulos A (1 January 2011). Color Atlas of Physiology. Thieme. pp. 305–. ISBN 978-3-13-149521-1.[↩]
44. Blackburn S (14 April 2014). Maternal, Fetal, & Neonatal Physiology. Elsevier Health Sciences. pp. 146–. ISBN 978-0-323-29296-2.[↩]
45. Wilson CB, Nizet V, Maldonado Y, Remington JS, Klein JO (24 February 2015). Remington and Klein’s Infectious Diseases of the Fetus and Newborn Infant. Elsevier Health Sciences. pp. 190–. ISBN 978-0-323-24147-2.[↩]
46. Estrogen and cognitive functioning in women: lessons we have learned. Behav Neurosci. 2011;126(1):123-7. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4838456/ [↩]
47. Hara Y, Waters EM, McEwen BS, Morrison JH (July 2015). “Estrogen Effects on Cognitive and Synaptic Health Over the Lifecourse”. Physiological Reviews. 95 (3): 785–807.[↩]
48. Korol DL, Pisani SL. Estrogens and cognition: Friends or foes?: An evaluation of the opposing effects of estrogens on learning and memory. Horm Behav. 2015;74:105-15. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4573330/[↩]
49. Estrogens, inflammation and cognition. Front Neuroendocrinol. 2016 Jan;40:87-100. doi: 10.1016/j.yfrne.2016.01.002. Epub 2016 Jan 12. https://doi.org/10.1016/j.yfrne.2016.01.002[↩]
50. Colzato LS, Hommel B. Effects of estrogen on higher-order cognitive functions in unstressed human females may depend on individual variation in dopamine baseline levels. Front Neurosci. 2014;8:65. Published 2014 Apr 7. doi:10.3389/fnins.2014.00065 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3985021/[↩]
51. The effects of estradiol on central serotonergic systems and its relationship to mood in women. Biol Res Nurs. 2007 Oct;9(2):147-60. https://www.ncbi.nlm.nih.gov/pubmed/17909167[↩]
52. Estrogen deficient male mice develop compulsive behavior. Biol Psychiatry. 2007 Feb 1;61(3):359-66. Epub 2006 Mar 29. https://www.ncbi.nlm.nih.gov/pubmed/16566897[↩]
53. Benmansour S, Weaver RS, Barton AK, Adeniji OS, Frazer A. Comparison of the effects of estradiol and progesterone on serotonergic function. Biol Psychiatry. 2012;71(7):633-41. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307822/[↩]
54. Changes in testosterone, cortisol, and estradiol levels in men becoming fathers. Mayo Clin Proc. 2001 Jun;76(6):582-92. https://www.ncbi.nlm.nih.gov/pubmed/11393496[↩]
55. Cao X, Xu P, Oyola MG, et al. Estrogens stimulate serotonin neurons to inhibit binge-like eating in mice. J Clin Invest. 2014;124(10):4351-62. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191033/[↩][↩][↩]
56. Eating disorders and depression: is there a serotonin connection? Biol Psychiatry. 1990 Sep 1;28(5):443-54. https://www.ncbi.nlm.nih.gov/pubmed/2207221[↩]
57. Klump KL, Keel PK, Racine SE, et al. The interactive effects of estrogen and progesterone on changes in emotional eating across the menstrual cycle. J Abnorm Psychol. 2012;122(1):131-7. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3570621/[↩]
58. Ovarian hormones and binge eating in bulimia nervosa. Psychol Med. 2007 Jan;37(1):131-41. Epub 2006 Oct 12. https://www.ncbi.nlm.nih.gov/pubmed/17038206[↩]
59. Klump KL, Racine SE, Hildebrandt B, et al. Ovarian Hormone Influences on Dysregulated Eating: A Comparison of Associations in Women with versus without Binge Episodes. Clin Psychol Sci. 2014;2(4):545-559. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203460/[↩][↩][↩]
60. Oestrogens and the heart. Therapie. 1999 May-Jun;54(3):381-5. https://www.ncbi.nlm.nih.gov/pubmed/10500455[↩]
61. Nadkarni S, Cooper D, Brancaleone V, Bena S, Perretti M. Activation of the annexin A1 pathway underlies the protective effects exerted by estrogen in polymorphonuclear leukocytes. Arterioscler Thromb Vasc Biol. 2011;31(11):2749-59. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3357483/[↩][↩]
62. Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Thompson LU, Boucher BA, Liu Z, Cotterchio M, Kreiger N. Nutr Cancer. 2006; 54(2):184-201. https://www.ncbi.nlm.nih.gov/pubmed/16898863/[↩]
63. Cornwell T, Cohick W, Raskin I. Dietary phytoestrogens and health. Phytochemistry. 2004;65(8):995–1016. https://www.ncbi.nlm.nih.gov/pubmed/15110680[↩]
64. Mazur W. Phytoestrogen content in foods. Baillieres Clin Endocrinol Metab. 1998;12(4):729–742. https://www.ncbi.nlm.nih.gov/pubmed/10384822[↩]
65. Patisaul HB, Jefferson W. The pros and cons of phytoestrogens. Frontiers in neuroendocrinology. 2010;31(4):400-419. doi:10.1016/j.yfrne.2010.03.003. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3074428/[↩]
66. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric. 2005 Aug;8 Suppl 1:3-63. https://doi.org/10.1080/13697130500148875[↩][↩]